1. |
Wang W, Yu P, Zhang P, et al. The infection of human primary cells and cell lines by human cytomegalovirus:new tropism and new reservoirs for HCMV[J]. Virus Res, 2008, 131(2):160-169.
|
2. |
Tuthill M, Chen F, Paston S, et al. The prevention and treatment of cytomegalovirus infection in haematopoietic stem cell transplantation[J]. Cancer Immunol Immunother, 2009, 58(9):1481-1488.
|
3. |
Sayers MH, Anderson KC, Goodnough LT, et al. Reducing the risk for transfusion-transmitted cytomegalovirus infection[J]. Ann Intern Med, 1992, 116(1):55-62.
|
4. |
陈玉成, 梁玉佳, 刘瑞, 等. 氧化低密度脂蛋白对血管内皮细胞骨架的损伤及其机制[J]. 心血管康复医学杂志, 2004, 13(4):320-321, 348.
|
5. |
Nieto FJ, Adam E, Sorlie P, et al. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis[J]. Circulation, 1996, 94(5):922-927.
|
6. |
Hendrix MG, Dormans PH, Kitslaar P, et al. The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and nonatherosclerotic patients[J]. Am J Pathol, 1989, 134(5):1151-1157.
|
7. |
王瑞金, 王得新, 王佳伟, 等. 巨细胞病毒感染对内皮细胞凝集素样氧化型低密度脂蛋白受体-1MRNA表达的影响[J]. 北京医学, 2006, 28(3):139-141.
|
8. |
Wentworth BB, Aleander ER. Sero epidemiology of infections due to members of the herpes virus group[J]. Am J Epidemiology, 1971, 94(6):496-507.
|
9. |
Gandhi MK, Khanna R. Human cytomegalovirus:clinical aspects, immune regulation, and emerging treatments[J]. Lancet Infect Dis, 2004, 4(12):725-738.
|
10. |
Michaelis M, Doerr HW, Cinatl J. The story of human cytomegalovirus and cancer:increasing evidence and open questions[J]. Neoplasia, 2009, 11(1):1-9.
|
11. |
Vanarsdall AL, Ryckman BJ, Chase MC, et al. Human cytomegalovirus glycoproteins gB and gH/gL mediate epithelial cell-cell fusion when expressed either in cis or in trans[J]. J Virol, 2008, 82(23):11837-11850.
|
12. |
Feire AL, Koss H, Compton T. Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain[J]. Proc Natl Acad Sci USA, 2004, 101(43):15470-15475.
|
13. |
Landry ML, Ferguson D, Cohen S, et al. Effect of delayed specimen processing on cytomegalovirus antigenemia test results[J]. J Clin Microbiol, 1995, 33(1):257-259.
|
14. |
Rubin RH. The indirect effects of cytomegalovirus infection on the outcome of organ transplantation[J]. JAMA, 1989, 261(24):3607-3609.
|
15. |
Varani S, Frascaroli G, Landini MP. Human cytomegalovirus targets different subsets of antigen-presenting cells with pathological consequences for host immunity:implications for immunosuppression, chronic inflammation and autoimmunity[J]. Rev Med Virol, 2009, 19(3):131-145.
|
16. |
Michaelis M, Doerr HW, Cinatl J. Oncomodulation by human cytomegalovirus:evidence becomes stronger[J]. Med Microbiol Immunol, 2009, 198(2):79-81.
|
17. |
Söderberg-Nauclér C. HCMV microinfections in inflammatory diseases and cancer[J]. J Clin Virol, 2008, 41(3):218-223.
|
18. |
Diao YT, Li H, Li HQ, et al. Association of serum levels of lipid and its novel constituents with the different stages of esophageal carcinoma[J]. Lipids Health Dis, 2009, 8(2):48-54.
|
19. |
Vielma SA, Mironova M, Ku JR, et al. Oxidized LDL further enhances expression of adhesion molecules in Chlamydophila pneumoniae-infected endothelial cells[J]. J Lipid Res, 2004, 45(5):873-880.
|